Gaelic Laboratories, a manufacturer of Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral dose Beta-Lactams, in a step that strengthens Gaelic’s market position, enhances manufacturing capabilities, and leverages supply chain efficiencies.

Both Gaelic Labs and Athlone are well established pharmaceutical manufacturers with strong reputations in Beta-Lactam antibiotics. According to the companies, combining their complementary offerings will enable them both to strengthen their market presence, enhance product offerings, and drive operational efficiencies. The acquisition also aligns with Gaelic Labs’ long-term vision to establish itself as a leader in the pharmaceutical industry, particularly in the production and distribution of Beta Lactam generic medicines.

“The deal is expected to deliver multiple financial and operational benefits, including cost savings through manufacturing consolidation, revenue growth and increased regulatory advantages,” says Brian Morrissey, General Manager of Gaelic Labs. “Athlone is a key player in the supply chain for Beta-Lactam antibiotics, so they are a great match for Gaelic Labs, and we will leverage many operational synergies.”

Gaelic Labs is committed to retaining personnel at the Athlone Labs site, including the current management team, ensuring operational continuity and a seamless transition for partners, suppliers and customers.  Athlone’s C-suite will now report to Brian Morrisey, who will have hierarchical responsibility over both companies.

“Gaelic Labs has always supported the creation of highly-skilled jobs in Ireland,” adds Morrisey. “With this acquisition, our total workforce has more than doubled to around 120 people, and we know that those people are the driving force behind our success. We are conducting several programs for smooth operational transitioning, and to ensure we retain the experience and expertise that Athlone has become known for.”

All existing product lines and customer contracts are expected to continue without disruption.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.